April 30, 2021

FRONTEO announces next-generation eDiscovery platform

Expanded the functions of the AI […]
May 6, 2020

FRONTEO Has Identified 450 Candidate Compounds In Its Research On The Novel Coronavirus (COVID-19)

April 30, 2020

FRONTEO has Constructed a Pathway Map of the Coronavirus Infection (COVID-19) to be Published for Use in Therapeutic Drug Selection and Review

April 17, 2020

FRONTEO Commences Drug Repositioning Research on Novel Coronavirus (COVID-19) Using Best-In-Class AI

April 15, 2020

FRONTEO and Kyowa Pharmaceutical Form Partnership to Diagnose Dementia Using Artificial Intelligence

April 15, 2020

FRONTEO Partners with Takeda Pharmaceutical for Drug Discovery and Development

March 25, 2020

FRONTEO Managed Review Service moved to remote-work using VDI solutions in light of recent outbreak of COVID-19

November 25, 2019

FRONTEO Performs PoC of its AI Review Tool “KIBIT Automator”, Representing a Major Step toward Larger Deployment in US

May 13, 2019

E-Discovery for the Globally Connected 21st Century Enterprise

April 29, 2019

FRONTEO Opens Low Cost Managed Review Center in Florida